Good morning. I'm Claude Maraoui, President, Chief Executive Officer, and a member of the Board of Directors of Journey Medical Corporation, and will be presiding over today's virtual meeting of stockholders. On behalf of our company, I want to welcome you to our 2026 Annual Meeting of Stockholders, which is now formally called to order. We are very pleased to have each of you in attendance at today's virtual meeting. Let me begin by introducing the other directors of the company in attendance via remote communication. With us today are Lindsay A. Rosenwald, MD, Justin Smith, Miranda Toledano, Neil Herskowitz, and Michael Pearce. Also present here today is Lindsay Phillips of KPMG, our independent auditors for the year ended December 31, 2025. David Wolpa of Troutman Pepper, our legal counsel, Ramsey Alloush, our Chief Operating Officer and General Counsel, who will serve as the secretary of the meeting, and Beth W. VanDerbeck, who will serve as Inspector of Elections of the meeting. Our order of business this morning will be to accept the motions to be considered, collect the votes, and then receive a preliminary report from the Inspector of Elections about the results. If you have any questions, please submit them to contact@jmcderm.com and we will address them after the meeting. This brings us to the first item on the agenda, which is the determination of a quorum. The bylaws and Delaware law provide that the presence in person or by proxy of a majority of the shares of stock issued and outstanding on the record date constitutes a quorum. Ms. VanDerbeck, do we have a quorum? Yes, we do. A majority of the shares of stock issued and outstanding as of the record date, April 28, 2026, are represented at the meeting. Thank you, Ms. VanDerbeck. There are two motions to be voted on by the stockholders. One, the first motion is the election of Lindsay A. Rosenwald, MD, Claude Maraoui, Justin Smith, Miranda Toledano, Neil Herskowitz, and Michael Pearce as directors to hold office until the annual meeting in 2027 or until their respective successors have been elected and qualified. The second motion is to ratify the appointment of KPMG as the company's independent registered public accounting firm for the 2026 fiscal year. All stockholders of record as of April 28, 2026, are entitled to vote at this virtual meeting and have the ability to do so online. If there is any stockholder of record as of April 28th, 2026, who has not voted by proxy and wants to vote, or who has previously voted by proxy but now wants to change that vote, you may now vote online by following the instructions available on the virtual meeting website. If you have already sent in your proxy card or otherwise voted for the Internet or by phone and do not want to change your vote, you do not need to do anything now. I'll now call the question on the following resolutions. Resolved, that the following persons hereby are elected as directors of the company to serve until the 2027 Annual Meeting of Stockholders or until their respective successors are elected and qualified. Lindsay A. Rosenwald, MD, Claude Maraoui, Justin Smith, Miranda Toledano, Neil Herskowitz, and Michael Pearce. Resolved that the appointment of KPMG to serve as the company's independent registered public accounting firm for the 2026 fiscal year is hereby ratified. At this moment, I'm going to officially close the polls. I want to thank everyone for your participation. I'll now ask the Inspector of Elections to report on the vote. Mr. Chairman, all of the nominees for director have been elected and the motion to ratify the appointment of KPMG as the company's independent registered public accounting firm for the 2026 fiscal year has been approved. Thank you, Ms. VanDerbeck. That completes our formal business for today and concludes the 2026 Annual Stockholders' Meeting. Thank you for joining today and for your support of Journey Medical Corporation. Let me now formally close this meeting. I will now open the floor to any questions to us or the representative from KPMG, our independent registered public accounting firm. Please submit any questions relevant to the meeting and pertinent to matters properly before the meeting, in accordance with the rules of the conduct for the meeting, using the online application